[Children hospitalized with influenza pneumonia AH1N1/2009 pandemic in the INSN]

Edwin Miranda-Choque1, Carlos Ramírez, Jorge Candela-Herrera

  • 1Servicio de Infectología, Instituto Nacional de Salud del Niño, Lima, Perú. emirandach@hotmail.com

Insights

Nosocomial viral pneumonia (NVP) cases during the 2009 H1N1 pandemic had higher mortality, particularly in children with pre-existing conditions. Early identification and intervention are crucial for managing severe influenza A H1N1 pneumonia.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Epidemiology

Context:

  • The 2009 influenza A H1N1 pandemic posed a significant threat to child health.
  • Pneumonia is a major complication of influenza, especially in pediatric populations.
  • Understanding the characteristics of H1N1-associated pneumonia is vital for clinical management.

Purpose:

  • To characterize the clinical and demographic features of children hospitalized with H1N1 pandemic influenza A virus (A H1N1/2009) pneumonia.
  • To identify risk factors associated with severe outcomes, including mortality and mechanical ventilation.
  • To differentiate between community-acquired and nosocomial viral pneumonia in the context of the H1N1 pandemic.

Summary:

  • A retrospective study of 74 children with confirmed A H1N1/2009 influenza pneumonia revealed distinct patterns.
  • Nosocomial viral pneumonia (NNv) cases demonstrated a statistically significant association with mortality, especially in children with pre-existing conditions like malnutrition and congenital heart disease.
  • Community-acquired viral pneumonia (NACv) predominantly affected children under 6 years, with fever, cough, and runny nose as common symptoms. Elevated C-reactive protein (CRP) levels correlated with respiratory failure.

Impact:

  • This study highlights the increased mortality risk associated with nosocomial viral pneumonia during the A H1N1/2009 pandemic.
  • Findings underscore the importance of recognizing pre-existing conditions as critical factors influencing outcomes in pediatric influenza pneumonia.
  • The data provides valuable insights for public health strategies and clinical protocols aimed at mitigating severe influenza A H1N1 pneumonia in children.
Abstract

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: